You are here: Industry Insights > M&As

News List

Evolving World of Pharma: Uniting pharma for value and innovation Sarah Harding
June 27, 2019
Pharma probably sees more M&A activity than any other industry, both in terms of the number of deals and the amount of money spent.
M&As this week: Sinclair Pharma, Direct Biologics pharmaceutical-technology
November 25, 2018
The deal will enable Sinclair to expand its product pipeline for minimally invasive treatments and build partnerships with aesthetic physicians and organisations in the US.
M&As this week: Sinclair Pharma, Direct Biologics pharmaceutical-technology
November 25, 2018
The deal will enable Sinclair to expand its product pipeline for minimally invasive treatments and build partnerships with aesthetic physicians and organisations in the US.
Deals and M&As this week: Alliance Pharma, Bayer, Onxeo pharmaceutical-technology
June 28, 2018
Alliance Pharma plans to acquire exclusive distribution rights to Nizoral, an anti-dandruff brand, from Janssen Pharmaceutica NV for £60m ($79.5m).
M&As this week: Intermediate Capital Group, Novartis pharmatimes
June 13, 2018
Intermediate Capital Group has completed the acquisition of SuanFarma from ProA Capital, a private equity firm based in Spain.
Summary of M&As in 2017 Dopine
January 08, 2018
2018 is here. I’d like to summarize characteristics of the M&As in the pharmaceutical field of 2017.
M&As this week: Clinigen Group, Mekong Capital expressbpd
August 28, 2017
M&As this week: Clinigen Group, Mekong Capital
M&As this week: Clinigen Group, Mekong Capital pharmaceutical-technology
August 25, 2017
M&As this week: Clinigen Group, Mekong Capital
M&As this week: Eurofins Scientific, Baxter International pharmaceutical-technology
August 07, 2017
Luxembourg-based life sciences company Eurofins Scientific plans to acquire DiscoverX, a reagents provider based in the US.
M&As this week: Huapont Life Sciences, Sosei Group pharmaceutical-technology
May 08, 2017
Chinese pharmaceutical company Huapont Life Sciences has announced plans to acquire 48.3% stake in a local tourist firm from a controlling shareholder.

Previous page 1 2 Next page